0001209191-13-038501.txt : 20130731
0001209191-13-038501.hdr.sgml : 20130731
20130731163049
ACCESSION NUMBER: 0001209191-13-038501
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130729
FILED AS OF DATE: 20130731
DATE AS OF CHANGE: 20130731
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Riley Wayne Joseph
CENTRAL INDEX KEY: 0001432895
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 13999395
MAIL ADDRESS:
STREET 1: 1005 DR D.B. TODD BLVD
CITY: NASHVILLE
STATE: TN
ZIP: 37208
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-07-29
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001432895
Riley Wayne Joseph
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2013-07-29
4
M
0
10000
33.89
A
10000
D
Common Stock
2013-07-29
4
S
0
9700
80.08
D
300
D
Common Stock
2013-07-29
4
S
0
100
81.18
D
200
D
Stock Option
33.89
2013-07-29
4
M
0
10000
0.00
D
2020-07-08
Common Stock
10000
20000
D
Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $80.08 (range $80.00 to $80.92).
Dr. Riley undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
The option vests in 16 quarterly installments from 07/09/2010.
Omar White, Attorney-In-Fact
2013-07-31